Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2020 | Targeted therapies for CLL

Lydia Scarfò, MD, Vita-Salute San Raffaele University & IRCCS San Raffaele Scientific Institute, Milan, Italy, talks on targeted therapies that are being developed for chronic lymphocytic leukemia (CLL), specifically discussing venetoclax, obinutuzumab and ibrutinib combinations as well as the addition of zanabrutinib This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).